Information for Doctors

Are you a DOCTOR looking for more details about our practice?

Thoracic Medicine

Think you might have a breathing disorder or just looking for more information?

Sleep Medicine

Latest News

As the official publication of the AASM, the online Journal of Clinical Sleep Medicine continues to gain a larger audience among both the general public and medical professionals by publishing high quality original articles


A new study has uncovered different survival traits in bacteria depending on the area they inhabit in the lung. The finding sheds light on why some treatments only work in parts of the lung.


1.6 million people are dying each year in China due to air pollution, according to a new study.


What Would You Give for a Better Night Sleep? Do you struggle with insomnia?


Saturday 1st August marked World Lung Cancer Day and the Forum of International Respiratory Societies (FIRS) has launched a month-long conversation about lung cancer: World Lung Cancer Day 2015: Honour, Unite, Inspire.


The American Academy of Sleep Medicine and Sleep Research Society recently released a Consensus Statement regarding the recommended amount of sleep to promote optimal health in adults.


Current trials

Patients needed for patent 1, patent 2 and chest clinical trials

PATENT 1, PATENT 2 and CHEST trials are currently underway at the Wesley Pulmonary Hypertension Unit and new patients are required.  We are trialing Riociuguat - a direct stimulator of the soluable Guanylate Cyclase which plays a significant role in the nitric oxide pathway and is intended for the treatment of PH. The trial is in association with Bayer and Wesley Research Institute.

In PATENT 1 & 2 trials, the patient can already be on therapy with an endothelin receptor antagonists (bosentan, sitaxentan or ambrisetan) or naïve to PAH therapy.

The CHEST trial is using the same agent for non-operable chronic thromboembolic disease related PAH.  (CTEPH)

We are accepting patients now for these trials by referral.

About The Wesley Pulmonary Hypertension Unit

The Wesley Pulmonary Hypertension Unit (WPHU) has established itself as one of the largest specialised treatment centres in Queensland.  In just 18 months of operation, the clinic has reviewed patients for treatment and have been actively enrolling patients into international clinical trials.  The treatment programs include monotherapy and combination treatments in keeping with the best available therapies for PAH.

Treatments Available

All PBS funded medications for monotherapy

Combination therapy – funded or via clinical trials

Clinical Trials with WRI

PATENT 1 and 2 trials

CHEST trial

Diagnostic Procedures

Cardiac Catherterisation
Nuclear imaging
MRI and CT
Complex Lung Testing CPET
Diagnostic Sleep Studies

The Wesley Pulmonary Hypertension Unit multidisciplinary team includes:

Dr Andrew Scott

Thoracic and Sleep Physician
P:  (07) 3876 8405
F:  (07) 3870 3212
E:   This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Dr David Cross
P:  (07) 3858 8600
F:   (07) 3870 4917
E:   This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Helen Woodhouse, CNC
WPHU Coordinator
P:  0404 650 281
F:  (07) 3871 3222
E:   This e-mail address is being protected from spambots. You need JavaScript enabled to view it

© copyright 2010 | All Rights Reserved | Web Design Brisbane by iFactory